Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis
Go back to Quantum BioPharma Submits Investigational New Drug (IND) Application to United States Food and Drug Administration (FDA) for Lucid-MS Phase Two Clinical Trial in Multiple Sclerosis| Quantum Technology Corp (NASDAQ: QNTM) | Delayed: 3.80 -0.13 (3.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.93 | 52 Week High | $2.00 | |||
| Open | $3.93 | 52 Week Low | $0.10 | |||
| Day High | $4.01 | P/E | N/A | |||
| Day Low | $3.64 | EPS | $0.00 | |||
| Volume | 104,356 | |||||
